Metamagnetics Announces Launch of Self-Biased Circulators
Product Line Built for Applications Across Aerospace and Defense Systems Features Breakthrough Design and Built Entirely Without Rare-Earth Magnets
Unlike circulators and isolators currently in use that require rare earth-based magnets, Metamagnetics' Self-Biased Circulators do not require a permanent magnet and are not dependent on
Metamagnetics' Self-Biased Circulators are critical to many Aerospace and Defense applications and are available from Ka band and above in microstrip form. The devices have a footprint of approximately 0.100-inch x 0.110-inch x 0.010-inch, and are more than 90% smaller in volume and mass compared to conventional products that utilize rare earth-based bias magnets. Metamagnetics' Self-Biased Circulators have survived excessive shock and vibration environments at levels greater than 50,000 g-forces, without any compromise in performance.
Metamagnetics' Self-Biased Circulators can be readily integrated into a variety of defense systems and are currently the only available devices of their kind that offer the unique combination of small form factor, strong performance and supply chain security.
ABOUT METAMAGNETICS
Metamagnetics develops and produces transformational solutions for customers in aerospace, defense and mission-critical domains. The company's high-frequency products are deployed across the most advanced intelligence, surveillance and communications systems. Metamagnetics' customers include the Department of Defense, other US Government Agencies, major US aerospace and defense prime contractors and leading technology companies. Metamagnetics is a Veteran-Owned Small Business and is based in the
Contact
President
[email protected]
781.571.2005
Senior Director, Sales and Business Development
[email protected]
774.405.7571
View original content to download multimedia:https://www.prnewswire.com/news-releases/metamagnetics-announces-launch-of-self-biased-circulators-302449393.html
SOURCE Metamagnetics
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novo Nordisk's denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026
- L&T Technology Services Global EI Hackathon Sparks the Next Wave of AI-Native Engineering Solutions
- PrimeBOT Brings Personal Robotics to the UN's AI for Good Summit in Geneva
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share